Literature DB >> 9224642

Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1).

H Nagase1, K Suzuki, T E Cawston, K Brew.   

Abstract

Tissue inhibitors of metalloproteinases (TIMPs) inhibit matrix metalloproteinases (MMPs) by forming a 1:1 stoichiometric complex, but the inhibition mechanism of these inhibitors is not known. Here we have investigated the reactive site of TIMP-1 by its proteinase susceptibility before and after forming a complex with MMP-3 (stromelysin 1). When TIMP-1 was allowed to react with human neutrophil elastase, its inhibitory activity was destroyed. This resulted from cleavage of the Val69-Cys70 bond. However, cleavage of this bond by neutrophil elastase was prevented when TIMP-1 formed a complex with the catalytic domain of MMP-3, and full TIMP-1 activity was restored after dissociation of the complex at pH 3.0 in the presence of EDTA. These results indicate that the region around Val69 closely associates with an active MMP. The three-dimensional structure of the N-terminal domain of TIMP-2 elucidated by NMR studies [Williamson, Martorell, Carr, Murphy, Docherty, Freedman and Feeney (1994) Biochemistry 33, 11745-11759] reveals that Val69 and Cys70 form part of an extended ridge that also includes the N-terminal section of the inhibitor. This region is probably involved in the interaction with the catalytic domains of MMPs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224642      PMCID: PMC1218541          DOI: 10.1042/bj3250163

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

Review 1.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling.

Authors:  J F Woessner
Journal:  FASEB J       Date:  1991-05       Impact factor: 5.191

2.  The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate.

Authors:  Y Okada; E D Harris; H Nagase
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

3.  Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor.

Authors:  G Murphy; P Koklitis; A F Carne
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

4.  Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP).

Authors:  R A Williamson; F A Marston; S Angal; P Koklitis; M Panico; H R Morris; A F Carne; B J Smith; T J Harris; R B Freedman
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

5.  Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4.

Authors:  J Greene; M Wang; Y E Liu; L A Raymond; C Rosen; Y E Shi
Journal:  J Biol Chem       Date:  1996-11-29       Impact factor: 5.157

6.  A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family.

Authors:  N Pavloff; P W Staskus; N S Kishnani; S P Hawkes
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

7.  Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases.

Authors:  Y Okada; S Watanabe; I Nakanishi; J Kishi; T Hayakawa; W Watorek; J Travis; H Nagase
Journal:  FEBS Lett       Date:  1988-02-29       Impact factor: 4.124

8.  Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13.

Authors:  M O'Shea; F Willenbrock; R A Williamson; M I Cockett; R B Freedman; J J Reynolds; A J Docherty; G Murphy
Journal:  Biochemistry       Date:  1992-10-27       Impact factor: 3.162

9.  The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity.

Authors:  G Murphy; A Houbrechts; M I Cockett; R A Williamson; M O'Shea; A J Docherty
Journal:  Biochemistry       Date:  1991-08-20       Impact factor: 3.162

10.  Purification of rabbit bone inhibitor of collagenase.

Authors:  T E Cawston; W A Galloway; E Mercer; G Murphy; J J Reynolds
Journal:  Biochem J       Date:  1981-04-01       Impact factor: 3.857

View more
  11 in total

1.  Expression and distribution of matrix metalloproteinases and their inhibitors in the human iris and ciliary body.

Authors:  J Lan; R K Kumar; N Di Girolamo; P McCluskey; D Wakefield
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

Review 2.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

3.  Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases.

Authors:  M H Biezeveld; G van Mierlo; R Lutter; I M Kuipers; T Dekker; C E Hack; J W Newburger; T W Kuijpers
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

Review 4.  The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases.

Authors:  H Senzaki
Journal:  Arch Dis Child       Date:  2006-10       Impact factor: 3.791

5.  Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction.

Authors:  Patricia L Jackson; Xin Xu; Landon Wilson; Nathaniel M Weathington; John Paul Clancy; James Edwin Blalock; Amit Gaggar
Journal:  Mol Med       Date:  2010-01-22       Impact factor: 6.354

6.  Insulin-like growth factor binding protein (IGFBP) substrate zymography. A new tool to identify and characterize IGFBP-degrading proteinases.

Authors:  J L Fowlkes; K M Thrailkill; D M Serra; H Nagase
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

7.  Effect of oral camostat mesilate on hematuria and/or proteinuria in children.

Authors:  Tadashi Asami; Shuichi Tomisawa; Makoto Uchiyama
Journal:  Pediatr Nephrol       Date:  2004-01-23       Impact factor: 3.714

8.  Chymase-mediated intestinal epithelial permeability is regulated by a protease-activating receptor/matrix metalloproteinase-2-dependent mechanism.

Authors:  Katherine R Groschwitz; David Wu; Heather Osterfeld; Richard Ahrens; Simon P Hogan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-01-10       Impact factor: 4.052

Review 9.  Serine proteinases in the turnover of the cartilage extracellular matrix in the joint: implications for therapeutics.

Authors:  David J Wilkinson; Maria Del Carmen Arques; Carmen Huesa; Andrew D Rowan
Journal:  Br J Pharmacol       Date:  2018-03-30       Impact factor: 8.739

10.  Mechanism of heparin acceleration of tissue inhibitor of metalloproteases-1 (TIMP-1) degradation by the human neutrophil elastase.

Authors:  Gabriel L C Nunes; Alyne Simões; Fábio H Dyszy; Claudio S Shida; Maria A Juliano; Luiz Juliano; Tarsis F Gesteira; Helena B Nader; Gillian Murphy; Alain F Chaffotte; Michel E Goldberg; Ivarne L S Tersariol; Paulo C Almeida
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.